Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans)
- PMID: 3281493
- DOI: 10.4269/ajtmh.1988.38.268
Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans)
Abstract
A protocol was developed for the testing of blood stage vaccines against Plasmodium falciparum using Peruvian Aotus vociferans and the Indochina I/CDC strain of the parasite. Three different fused polypeptide vaccines containing elements of the ring-infected erythrocyte surface antigen molecule combined with Freund's complete and Freund's incomplete adjuvants were tested to determine their ability to protect against overwhelming infection following challenge with this highly virulent strain of P. falciparum, and to invoke antibody responses as measured by a standard indirect immunofluorescence technique. Nine of 14 immunized animals exhibited some protection. Presented are the test procedures developed for the conduct of such trials with New World monkeys and the analysis of results that led to the identification of variables selected for study in future trials.
Similar articles
-
Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.Am J Trop Med Hyg. 1991 Jan;44(1):34-41. doi: 10.4269/ajtmh.1991.44.34. Am J Trop Med Hyg. 1991. PMID: 1996739
-
Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant.Infect Immun. 1993 May;61(5):2048-52. doi: 10.1128/iai.61.5.2048-2052.1993. Infect Immun. 1993. PMID: 8478093 Free PMC article.
-
Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:413-22. doi: 10.1590/s0074-02761992000700070. Mem Inst Oswaldo Cruz. 1992. PMID: 1343721
-
Structure and function of candidate vaccine antigens in Plasmodium falciparum.Biochem Soc Symp. 1987;53:103-14. Biochem Soc Symp. 1987. PMID: 3332761 Review.
-
Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review.Z Parasitenkd. 1986;72(1):1-11. doi: 10.1007/BF00927730. Z Parasitenkd. 1986. PMID: 3515789 Review. No abstract available.
Cited by
-
Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.Infect Immun. 2001 Apr;69(4):2558-68. doi: 10.1128/IAI.69.4.2558-2568.2001. Infect Immun. 2001. PMID: 11254620 Free PMC article.
-
Future potential of malaria vaccines.J R Soc Med. 1989;82 Suppl 17(Suppl 17):57-62. J R Soc Med. 1989. PMID: 2693728 Free PMC article. Review. No abstract available.
-
Role of non-human primates in malaria vaccine development: memorandum from a WHO meeting.Bull World Health Organ. 1988;66(6):719-28. Bull World Health Organ. 1988. PMID: 3266112 Free PMC article.
-
Plasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasion.Infect Immun. 1991 Mar;59(3):1183-7. doi: 10.1128/iai.59.3.1183-1187.1991. Infect Immun. 1991. PMID: 1997422 Free PMC article.
-
Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria.Clin Exp Immunol. 1991 Apr;84(1):122-8. doi: 10.1111/j.1365-2249.1991.tb08134.x. Clin Exp Immunol. 1991. PMID: 2015702 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical